Implant-associated anaplastic large T-cell lymphoma (BIA-ALCL): case report

▪ ABSTRACT

Recognized by the World Health Organization in 2016, breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon subtype of T-cell non-Hodgkin lymphoma that develops after the insertion of breast implants. The disease is a rare condition that affects approximately one in every 30,000 people with textured breast implants. The main clinical manifestations are late seroma, breast asymmetry, mass, and capsular contracture, with a higher frequency of the former. Explantation of the prosthesis with total capsulectomy may be sufficient to treat ALCL, with resections extended to adjacent sites when necessary. However, in some cases, adjuvant radiotherapy and/or chemotherapy is performed. It is concluded that, for an early diagnosis and effective treatment, women with sudden and late-onset seroma should undergo additional tests to exclude this condition, even with a shorter development time than the average, which is around 10.6 years.

Keywords:

Lymphoma, large-cell, anaplastic - Positron-emission tomography - Lymphoma, non-Hodgkin - Seroma - Breast implantation

Institution: Fundação Hospitalar do Estado de Minas Gerais (FHEMIG), Belo Horizonte, MG, Brazil.

Publikationsverlauf

Eingereicht: 20. November 2023

Angenommen: 30. April 2024

Artikel online veröffentlicht:
20. Mai 2025

• REFERÊNCIAS

• 1 Silva ACC, Pereira APA, Bicalho BC, Avelar CC, Abreu EDFA, Camarano GCV. et al. Linfoma anaplásico de grandes células associado a implante mamário: uma revisão narrativa. Rev Eletr Acervo Saúde 2020; 12 (11) e4767 . Disponível em: https://acervomais.com.br/index.php/saude/article/view/4767
• 2 Monteiro LL, Mangiavacchi W, Machado DG. A evolução das próteses mamárias e os métodos de incisão utilizados em procedimentos de mamoplastia de aumento. Rev Bras Cir Plást 2022; 37 (01) 125-131
• 3 Batista BN, Garicochea B, Aguilar VLN, Carvalho FM, Millan LS, Fraga MFP. et al. Relato de caso de linfoma anaplásico de células grandes associado a implante mamário em paciente brasileira. Rev Bras Cir Plást 2017; 32 (03) 445-449
• 4 Veloso CN, Abbas K, Tonin JMF. Cirurgia plástica: qual o custo da indústria da beleza? Anais do Congresso Brasileiro de Custos - ABC. Uberlândia: XX Congresso Brasileiro de Custos; 2013. . Disponível em: https://anaiscbc.emnuvens.com.br/anais/article/view/20
• 5 Real DSS, Resendes BS. Linfoma anaplásico de grandes células relacionado ao implante mamário: revisão sistemática da literatura. Rev Bras Cir Plást 2019; 34 (04) 531-538
• 6 Lee JH. Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL). Yeungnam Univ J Med 2021; 38 (03) 175-182
• 7 Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J 2019; 39 (Suppl. 1) S3-S13
• 8 Berlin E, Singh K, Mills C, Shapira I, Bakst RL, Chadha M. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Case Report and Review of the Literature. Case Rep Hematol 2018; 2018: 2414278-2414278
• 9 Keech Jr JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg 1997; 100 (02) 554-555
• 10 Pastorello RG, D’Almeida Costa F, Osório CABT, Makdissi FBA, Bezerra SM, de Brot M. et al. Breast implant-associated anaplastic large cell lymphoma in a Li-FRAUMENI patient: a case report. Diagn Pathol 2018; 13 (01) 10-10
• 11 Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T. et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg 2017; 140 (04) 645-654
• 12 Johnson L, O’Donoghue JM, McLean N, Turton P, Khan AA, Turner SD. et al. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent. Eur J Surg Oncol 2017; 43 (08) 1393-1401